Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients.
(2021) Journal of neurology — Vol. 268, n° 11, p. 4376-4378 (2021)
Files
Sankari2021_Article_CutaneousDiseasesRelatedToAHyp.pdf
Open Access - Adobe PDF
- 654.15 KB
Details
- Authors
- Abstract
- (en) DEAR SIRS, Whereas, B-cell depletion has proven very efcient at controlling disease activity in several auto-immune diseases, including MS, long-term or rare side efects of the treatment remain unknown. Adverse events related to B-cell depletion are notably an increase in the risk of shingles, herpesvirus infection or hypogammaglobulinemia […]
- Affiliations
Citations
El Sankari, S., Van Essche, C., & Van Pesch, V. (2021). Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients. Journal of neurology, 268(11), 4376-4378. https://doi.org/10.1007/s00415-021-10679-3 (Original work published 2021)